744.6000 4.30 (0.58%)
NSE Sep 19, 2025 15:31 PM
Volume: 380.5K
 

Axis Direct
We believe KIMS has a structural growth story (strong ROCE of 32%). It is also a zero net-debt company due to its strong operating cash flow generation. Keeping this in perspective, we recommend a BUY rating on the stock with a TP of Rs 1,570/share.
Krishna Institute of.. has an average target of 752.22 from 9 brokers.
More from Krishna Institute of Medical Sciences Ltd.
Recommended